News

Valvoline Inc. Announces Fourth Quarter 2024 Earnings Call

Valvoline Inc. Announces Fourth Quarter 2024 Earnings Call

Valvoline Inc. Prepares for Fourth Quarter Financial Results

Valvoline Inc. (NYSE: VVV), a leader in preventive automotive maintenance, has exciting news for its stakeholders. The company is set to report its financial outcomes for the fiscal fourth quarter. On the announced date, analysts and investors will be invited to join a live audio webcast, further enhancing transparency and stakeholder engagement.

Webcast Details and Financial Highlights

Scheduled for an engaging session, the webcast is expected to shed light on the company’s performance, reaffirming its position as a trusted name in automotive care. This call will occur on the same day as the earnings report release, providing a seamless flow of information. Stakeholders are encouraged to tune in and hear directly from company executives regarding the results and forward-looking strategies.

Significance of the Quarter

The fourth quarter is pivotal for Valvoline as it showcases the culmination of the fiscal year’s efforts. Investors will look to understand how the company has performed amidst various market challenges and what this means for future growth. Historically, this quarter is indicative of how well the company executed its business strategies throughout the year.

Valvoline's Commitment to Quality Service

Valvoline Inc. is renowned for its extensive network of service centers across North America, comprising nearly 2,000 locations. The company emphasizes providing quick and reliable service, including essential maintenance like oil changes, battery replacements, and tire rotations. The focus on customer satisfaction is evidenced by an impressive customer service rating of 4.6 out of 5 stars, showcasing the dedication Valvoline has towards its clientele.

Achievements and Growth Metrics

In the recent fiscal year, Valvoline delivered over 28 million services, contributing significantly to the company's revenue stream. The reported figures highlight that Valvoline generated $1.4 billion from a total of $2.8 billion in system-wide store sales. This consistent growth demonstrates the company’s robust market presence and the effectiveness of their operational strategies over the past 17 years.

Valvoline's Workforce and Franchise Success

Success at Valvoline is driven by its workforce of more than 10,000 dedicated team members. The company prides itself not only on the professional development of its staff but also on the fruitful relationships it has maintained with franchise partners. This partnership has been integral to Valvoline's expansion and service delivery.

Award-Winning Service and Recognition

Valvoline has been a standout in the quick lube sector, having won notable awards such as the BEST Award for training excellence. Additionally, it has been recognized as a top-rated franchisor in its category, underlining its commitment to quality and operational excellence.

Contact Information for Stakeholders

For further information about the upcoming financial report or other inquiries, stakeholders can reach out through the following contacts:

Investor Relations:
Elizabeth B. Clevinger
+1 (859) 357-3155

Media Relations:
Angela Davied
+1 (913) 302-0032

Frequently Asked Questions

What is the date of Valvoline's fourth-quarter earnings report?

Valvoline Inc. will announce its fourth-quarter earnings on November 19.

Where can I access the webcast?

The audio webcast will be available on Valvoline’s Investor Relations website.

How many service centers does Valvoline operate?

Valvoline operates nearly 2,000 service centers across North America.

What revenue did Valvoline generate last year?

Valvoline generated $1.4 billion in revenue from system-wide store sales of $2.8 billion last fiscal year.

Who can I contact for investor information?

For investor relations queries, you can contact Elizabeth B. Clevinger at +1 (859) 357-3155.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles